Modified Creatinine Index and Clinical Outcomes of Hemodialysis Patients: An Indicator of Sarcopenia?

Sarcopenia (especially muscle mass assessed using gold standard techniques) has been suggested as a poorer predictor of mortality than muscle function in patients undergoing hemodialysis. Appropriate methods to estimate muscle mass for use as a good predictor of clinical outcomes remain to be established. We investigated whether the modified creatinine index (mCI), which is a surrogate marker of muscle mass, could predict mortality and cardiovascular (CV) hospitalizations independent of muscle function and other confounders in patients on hemodialysis.

Source: Journal of Renal Nutrition - September 16, 2020 Category: Urology & Nephrology Authors: Shohei Yamamoto, Ryota Matsuzawa, Keika Hoshi, Yuta Suzuki, Manae Harada, Takaaki Watanabe, Yusuke Isobe, Keigo Imamura, Shiwori Osada, Atsushi Yoshida, Kentaro Kamiya, Atsuhiko Matsunaga Tags: Original Research Source Type: research